Photo of Richard D. Press, M.D., Ph.D.

Richard D. Press M.D., Ph.D.

  •      (503) 494-8276
    • Professor of Pathology School of Medicine
    • Director, Molecular Pathology and Molecular Diagnostics Laboratories
    • Molecular Genetic Pathology Fellowship Program Director
    • Molecular and Medical Genetics Graduate Program School of Medicine
    • Program in Molecular and Cellular Biosciences School of Medicine

Dr. Press is the director of molecular pathology and the Molecular Diagnostics Center at the OHSU Knight Cancer Institute, and program director for the molecular genetic pathology fellowship. His research interests include molecular diagnostic biomarkers in cancer and infectious diseases and prevalent genetic alterations in common diseases. Dr. Press received his M.D. and Ph.D. in 1988 at Case Western Reserve University in Cleveland.


  • B.A., Northwestern University, Evanston Illinois 1981
  • M.D., Ph.D., Case Western Reserve University, Cleveland Ohio 1988
  • Residency:

    • Pathology, University of Pennsylvania, Philadelphia
  • Fellowship:

    • Molecular pathology, University of Pennsylvania, Philadelphia
  • Certifications:

    • Clinical Pathology, American Board of Pathology, 1992
    • Molecular Genetic Pathology, American Board of Pathology & American Board of Medical Genetics, 2001


  • "Role of a common mutation in the homocysteine regulatory enzyme methylenetetrahydrofolate reductase in ischemic stroke" Diagnostic Molecular Pathology March 1999
  • "HFE, SLC40A1, HAMP, HJV, TFR2, and FTL mutations detected by denaturing high-performance liquid chromatography after iron phenotyping and HFE C282Y and H63D genotyping in 785 HEIRS Study participants" American Journal of Hematology November 2009
  • "Detection of prevalent genetic alterations predisposing to hemochromatosis and other common human diseases" Clinical Chemistry  2000
  • "Transformation of chicken myelomonocytic cells by a retrovirus expressing the v-myb oncogene from the long terminal repeats of avian myeloblastosis virus but not rous sarcoma virus" Journal of Virology September 1992
  • "Hepatic iron overload" American Journal of Clinical Pathology  1998
  • "Quantitative BCR-ABL1 RQ-PCR fusion transcript monitoring in chronic myelogenous leukemia"   2013
  • "New Food and Drug Administration-based oversight over genetic testing." Molecular Diagnosis and Therapy December 2001
  • "Overestimation of HFE C282Y homozygous hemochromatosis prevalence as the result of a common primer-binding site polymorphism" Molecular Diagnosis and Therapy  1999
  • "Pathogen analysis and genetic predisposition testing using microelectronic arrays and isothermal amplification" Journal of Investigative Medicine  2000
  • "MYD88 mutation analysis of a rare composite chronic lymphocyte leukemia and lymphoplasmacytic lymphoma by flow cytometry cell sorting" Annals of Hematology November 22 2015
  • "A genome-wide linkage scan for iron phenotype quantitative trait loci" Clinical Genetics June 2007
  • "Predisposition to thrombosis by a factor V mutation causing hereditary resistance to activated protein C" Western Journal of Medicine  1995
  • "Diagnostic molecular pathology"   2006
  • "Hereditary hemochromatosis" Archives of Pathology and Laboratory Medicine  1999
  • "Association of JAK2 mutation status and cytogenetic abnormalities in myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms" American Journal of Clinical Pathology May 2011
  • "Thrombophilic mutations impart a high risk of pregnancy-related venous thrombosis." Molecular Diagnosis and Therapy June 2000
  • "Human Papillomavirus DNA detection for cervical cancer screening." Molecular Diagnosis and Therapy September 2000
  • "HFE C282Y homozygotes aged 25-29 years at HEIRS study initial screening" Genetic Testing and Molecular Biomarkers September 1 2007
  • "Crohn's disease is caused by mutations in the bacterial response protein NOD2." Molecular Diagnosis and Therapy December 2001
  • "BCR-ABL1 Compound Mutations Combining Key Kinase Domain Positions Confer Clinical Resistance to Ponatinib in Ph Chromosome-Positive Leukemia" Cancer Cell  2014
  • "Clinical news update." Molecular Diagnosis and Therapy March 2001
  • "Expression and stability of c-sis mRNA in human glioblastoma cells" Biochemistry  1988
  • "Characterization of BCR-ABL deletion mutants from patients with chronic myeloid leukemia" Leukemia June 2008
  • "An outbreak of acute hepatitis C among recipients of intravenous immunoglobulin" Annals of Allergy, Asthma and Immunology February 1996
  • "Clinical implementation of next-generation sequencing" Clinical Advances in Hematology and Oncology  2014
  • "BCR-ABL SH3-SH2 domain mutations in chronic myeloid leukemia patients on imatinib" Blood October 28 2010
  • "The clinical impact of coronavirus infection in patients with hematologic malignancies and hematopoietic stem cell transplant recipients" Journal of Clinical Virology July 1 2015
  • "Major molecular response in CML patients treated with tyrosine kinase inhibitors" Oncologist  2010
  • "Lack of prothrombin gene mutation in young stroke patients" Journal of Stroke and Cerebrovascular Diseases  2000
  • "Multicenter evaluation of PCR methods for the detection of factor V Leiden (R506Q) genotypes" Clinical Chemistry  1998

Additional information

Edit profile